If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
77.00    1.40 (1.82%)
Bid:
77.00
Ask:
79.80
Spread: 2.80 (3.636%)
Market Cap: £103.98m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Holding(s) in Company

16 Dec 2011 11:52

RNS Number : 1492U
Trifast PLC
16 December 2011
 



For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Trifast PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Completion of a placing

X

3. Full name of person(s) subject to thenotification obligation: iii

NFU Mutual Insurance Society Limited

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14th December 2011

6. Date on which issuer notified:

16th December 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

> 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary shares

1,483,822

1,483,822

3,233,822

3,233,822

3.03%

GB0008883927

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,233,822

3.03%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Adam Carroll

15. Contact telephone number:

01789 202203

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDKADPDBDDDBD
Date   Source Headline
26th Jul 20227:00 amRNSPublication of the 2022 Annual Results
12th Jul 20224:36 pmRNSHolding(s) in Company
4th Jul 20228:00 amRNSNotice of 2022 Annual results
7th Jun 20225:56 pmRNSHolding(s) in Company - Replacement
7th Jun 20224:28 pmRNSHolding(s) in Company
1st Jun 20227:01 amRNSDirector Declaration
25th May 20222:36 pmRNSTotal Voting Rights
24th May 20227:00 amRNSNotice of Results - Amendment to timing of release
17th May 20227:00 amRNSHolding(s) in Company
5th May 20224:40 pmRNSSecond Price Monitoring Extn
5th May 20224:35 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSTrading update & Notice of Annual results
20th Apr 20229:51 amRNSBlock listing Interim Review
6th Apr 20224:40 pmRNSSecond Price Monitoring Extn
6th Apr 20224:35 pmRNSPrice Monitoring Extension
16th Mar 20224:35 pmRNSPrice Monitoring Extension
14th Mar 20225:30 pmRNSTotal Voting Rights
14th Mar 20221:47 pmRNSHolding(s) in Company
9th Mar 20224:36 pmRNSPrice Monitoring Extension
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20221:23 pmRNSHolding(s) in Company
3rd Mar 20225:10 pmRNSHolding(s) in Company
24th Feb 20227:00 amRNSQ3 Trading Update
2nd Feb 202211:32 amRNSTotal Voting Rights
7th Dec 20211:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20214:22 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSHALF-YEARLY FINANCIAL REPORT TO 30 SEPTEMBER 2021
11th Nov 20211:48 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSTrading update and Notice of half-year results
1st Oct 202112:00 pmRNSBlock listing Interim Review
1st Sep 20217:00 amRNSTR acquisition -enhancing North American offering
4th Aug 20214:27 pmRNSLTIP Grant and Total Voting Rights
29th Jul 20214:27 pmRNSResult of AGM
28th Jul 20217:00 amRNSAGM Statement to Shareholders
26th Jul 20215:19 pmRNSAnnual General Meeting -shareholderupdate
29th Jun 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20215:51 pmRNSAvailability of 2021 Annual Financial Report
28th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20217:00 amRNS2021 Annual Results - year ended 31 March 2021
14th Jun 202110:29 amRNSTotal Voting Rights
23rd Apr 202112:32 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSTrading Update & Notice of Annual Results
1st Apr 20217:00 amRNSBlock listing Interim Review
1st Apr 20217:00 amRNSTotal Voting Rights
12th Mar 20215:48 pmRNSDirector/PDMR Shareholding
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSTrading Update
16th Feb 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.